Vivesto AB (STO:VIVE)
Sweden · Delayed Price · Currency is SEK 8.98
-0.01 (-0.11%)
Aug 14, 2026, 5:22 PM CET
Vivesto AB Market Cap
Vivesto AB has a market cap or net worth of 99.42 million as of August 14, 2026. Its market cap has decreased by -23.64% in one year.
Market Cap
99.42M
Enterprise Value
67.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.98
ChartMarket Cap Chart
Since August 11, 2006, Vivesto AB's market cap has decreased from 1.15B to 99.42M, a decrease of -91.36%. That is a compound annual growth rate of -11.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 99.42M | 36.88% |
| Dec 30, 2025 | 72.64M | -53.45% |
| Dec 30, 2024 | 156.03M | -28.83% |
| Dec 29, 2023 | 219.25M | -6.11% |
| Dec 30, 2022 | 233.51M | -80.14% |
| Dec 30, 2021 | 1.18B | -36.33% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 844.47M |
| EQL Pharma AB | 776.63M |
| Dicot Pharma AB | 724.26M |
| Cinclus Pharma Holding AB | 550.08M |
| Orexo AB | 530.81M |
| Moberg Pharma AB | 520.77M |
| Enzymatica AB | 473.33M |
| Klaria Pharma Holding AB (publ.) | 233.43M |